Status:
COMPLETED
Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Dementia
Alzheimer Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
STELLA (Support via Technology Living and Learning with Advancing Alzheimer's disease and related dementias) is a multicomponent video-conference based intervention that aims to help family members ca...
Detailed Description
Introduction and Specific Aims: Family members who care for those with Alzheimer's disease and related dementias (ADRD) may find a sense of meaning, opportunity and power in their evolving role, but ...
Eligibility Criteria
Inclusion
- Care Recipient Inclusion:
- Diagnosis of Alzheimer's Disease and Related Dementias (ADRD), moderate to late stages
- Exhibits 2 or more behaviors listed on Revised Memory and Behavioral Problems (RMBP) that are bothersome to the Care Partner and occur 3 or more times/week at study enrollment
- Family member of Care Partner (this can be a relative, spouse or close kin that is considered family)
- Care Recipient Exclusion:
- Dementia not related to ADRD
- Unable to leave Care Partner during Care Partner training
- Early stage dementia, as defined by a Montreal Cognitive Assessment (MoCA) of about 15/30 or higher.
- Care Partner Inclusion:
- Adult caring for family member with ADRD
- Lives with care recipient OR spends at least 4 hours/week with care recipient
- Age of 18 years or older
- Speak English
- Own a computer/device with a reliable internet connection and compatible operating system
- Care Partner Exclusion:
- Unable to find activity for care recipient during training which would allow Care Partner to work privately, one-on-one during training
- Completed similar telehealth intervention within the last year
- Hearing and vision problems severe enough to prevent participation
- Unwilling or unable to adequately follow study instructions and participate in study procedures
- Inclusion for Care Recipient and Care Partner:
- Participate in Oregon Roybal Center for CAre Support Translational Research Advantaged by Integrating Technology (ORCASTRAIT) (IRB#20236) Participant in the ORCASTRAIT study (IRB # 20236)
Exclusion
Key Trial Info
Start Date :
March 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04335110
Start Date
March 24 2021
End Date
June 15 2023
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health and Science University, Layton Aging and Alzheimer's Disease Center
Portland, Oregon, United States, 97239